| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/08/2004 | WO2004029244A1 Animal cells having chimeric receptor and utilization thereof |
| 04/08/2004 | WO2004029235A2 Aldehyde dehydrogenase gene |
| 04/08/2004 | WO2004029231A1 Compositions and methods for amplification of human stem cells |
| 04/08/2004 | WO2004029230A2 Cells on a support matrix for tissue repair |
| 04/08/2004 | WO2004029229A2 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/08/2004 | WO2004029226A2 Methods for altering cell fate to generate t-cells specific for an antigen of interest |
| 04/08/2004 | WO2004029221A2 Microfluidic device for cell separation and uses thereof |
| 04/08/2004 | WO2004029211A2 Frozen spermatozoa compositions and uses thereof |
| 04/08/2004 | WO2004029208A2 Cell separation compositions and methods |
| 04/08/2004 | WO2004029203A2 Compositions and methods for enrichment of neural stem cells using ceramide analogs |
| 04/08/2004 | WO2004029200A2 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 04/08/2004 | WO2004029137A2 Cross-linked polymer matrices, and methods of making and using same |
| 04/08/2004 | WO2004029069A2 Hybridomas producing high levels of human sequence antibody |
| 04/08/2004 | WO2004028554A2 Skrp, astray, string, vacm associated with metabolic control |
| 04/08/2004 | WO2004028546A1 Cholesterol efflux and uses thereof |
| 04/08/2004 | WO2004028339A2 Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues |
| 04/08/2004 | WO2004028243A2 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 04/08/2004 | WO2004018654A3 Cell culture surface |
| 04/08/2004 | WO2004015091A3 Preparation of type ii pneumocytes from stem cells |
| 04/08/2004 | WO2004014952A3 Specific probnp(1-108) antibodies for diagnosing heart failure |
| 04/08/2004 | WO2004012658A3 Method and device for protein delivery into cells |
| 04/08/2004 | WO2004011631A3 Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus |
| 04/08/2004 | WO2004011596A3 Method for preparing an extracellular matrix and its use for tumor cell culture |
| 04/08/2004 | WO2004007699A3 Method for preparing engineered tissue |
| 04/08/2004 | WO2004006840A3 Three dimensional cell patterned bioploymer scaffolds and method of making the same |
| 04/08/2004 | WO2004004687A3 Liposomal vaccine |
| 04/08/2004 | WO2004003182A3 Homozygous stem cells isolated from pathogenic oocytes |
| 04/08/2004 | WO2003106684A3 A method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 04/08/2004 | WO2003104428A3 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003100008A3 Neutralizing human anti-igfr antibody |
| 04/08/2004 | WO2003095976A3 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 04/08/2004 | WO2003078597A3 Tissue engineering |
| 04/08/2004 | WO2003077852A3 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β |
| 04/08/2004 | WO2003076610A3 Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
| 04/08/2004 | WO2003076602A3 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo |
| 04/08/2004 | WO2003072748A3 Bioengineered tissue substitutes |
| 04/08/2004 | WO2003070974A3 Mismatch repair detection |
| 04/08/2004 | WO2003070083A3 Endothelial precursor cells for enhancing and restoring vascular function |
| 04/08/2004 | WO2003066843A3 Method for the production of a nerve transplant |
| 04/08/2004 | WO2003064468A3 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | WO2003044037A3 Process for the manufacture of human mononuclear phagocytic leukocytes |
| 04/08/2004 | WO2003042249A8 Peptide purification by means of metal ion affinity chromatography |
| 04/08/2004 | WO2003022123A9 Methods of kidney transplantation utilizing developing nephric tissue |
| 04/08/2004 | WO2003011313A8 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 04/08/2004 | WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use |
| 04/08/2004 | WO2002090528A9 Soft tissue devices and methods of use |
| 04/08/2004 | WO2002086082A3 Isolation of neural stem cells using gangliosides and other surface markers |
| 04/08/2004 | WO2002083854A3 Antibodies to vla-1 |
| 04/08/2004 | WO2002081668A9 Desaturase genes and uses thereof |
| 04/08/2004 | WO2002072762A9 Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| 04/08/2004 | WO2002058546A3 Methods for screening for substances which inhibit fp prostanoid receptor |
| 04/08/2004 | WO2002044319A3 Spatially directed ejection of cells from a carrier fluid |
| 04/08/2004 | WO2002030470A8 Methods and compositions for nucleic acid delivery |
| 04/08/2004 | US20040068762 Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/08/2004 | US20040067586 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
| 04/08/2004 | US20040067585 Cell cultivation surface and method of making the same |
| 04/08/2004 | US20040067584 Defined systems for epithelial cell culture and use thereof |
| 04/08/2004 | US20040067583 Methods for immortalizing cells |
| 04/08/2004 | US20040067582 Preparing metabolically non-viable and/or reproductively non-viable cells for use in tissue transplantation and grafting; prosthetics |
| 04/08/2004 | US20040067581 Nutrient broth for propagation cancerous tissues; diagnosing cell proliferative disorders |
| 04/08/2004 | US20040067580 Human foreskin cells suitable for culturing stem cells |
| 04/08/2004 | US20040067552 Adipocyte complement related protein zacrp14 |
| 04/08/2004 | US20040067546 Pore-sized controlled porous filter membrane outspace side coated with cell adhesion layer and combines neuronal cells with filter membrane in aqueous environment under conditions in which outgrown neurites from cells attracted to surface |
| 04/08/2004 | US20040067524 Chlamydia protein, gene sequence and uses thereof |
| 04/08/2004 | US20040067518 Isolated nucleic acid comprising a polynucleotide of given sequence; polypeptides; recombinant host cells; useful in diagnosing and treating disorders |
| 04/08/2004 | US20040067515 Human proteinase molecules |
| 04/08/2004 | US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067486 Nucleic acid containing one or more adaptive mutations, and Hepatitis c Virus (HCV) replicon enhanced cells ( cells having an increased ability to maintain an HCV replicon) |
| 04/08/2004 | US20040067249 Implant comprising a pair of bone anchors joined at their proximal ends by at least one support filament coated by a matrix layer of thickness sufficient to allow for colonization by a cell; tissue engineering |
| 04/08/2004 | US20040067242 Multi-subtype FIV vaccines |
| 04/08/2004 | US20040067222 Regulation of glucocorticoid concentration |
| 04/08/2004 | US20040067221 Cell delivery fluid for prevention of cell settling in delivery system |
| 04/08/2004 | US20040067219 Method for harvesting fat cells from a fat-fluid mixture |
| 04/08/2004 | US20040067218 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissue |
| 04/08/2004 | DE10158680B4 Verfahren zur ex vivo-Expansion und -Differenzierung von multipotenten Stammzellen A method for ex vivo expansion and differentiation of multipotent stem cells |
| 04/08/2004 | CA2840692A1 Fvii or fviia variants having increased clotting activity |
| 04/08/2004 | CA2523618A1 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/08/2004 | CA2500397A1 Aav itr-mediated modulation |
| 04/08/2004 | CA2500210A1 Cholesterol efflux and uses thereof |
| 04/08/2004 | CA2500179A1 Cells on a support matrix for tissue repair |
| 04/08/2004 | CA2500040A1 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 04/08/2004 | CA2499872A1 Cross-linked polymer matrices, and methods of making and using same |
| 04/08/2004 | CA2499826A1 Cell separation compositions and methods |
| 04/08/2004 | CA2498058A1 N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses |
| 04/08/2004 | CA2496761A1 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 04/07/2004 | EP1405922A2 Substrates for beta-lactamase and uses thereof |
| 04/07/2004 | EP1405911A1 Interaction trap systems for detecting protein interactions |
| 04/07/2004 | EP1405908A1 Creation of high yield heterologous expression cell lines |
| 04/07/2004 | EP1405906A1 Schwann cells originating in myeloid interstitial cells |
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1405079A2 Modulation of the interaction between evh1 domains |
| 04/07/2004 | EP1405068A1 Methods for cloning mammals using remodeling factors |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404871A2 Method for treatment of cancer associated with elevated her 2 levels |
| 04/07/2004 | EP1404868A2 Compositions and methods relating to osteoarthritis |
| 04/07/2004 | EP1404863A1 PIBs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE |